Print

Apricus Biosciences (APRI) Reports Corporate Update  
8/12/2013 9:43:44 AM

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

SAN DIEGO, Aug. 12, 2013 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio" or the "Company") (Nasdaq:APRI) (www.apricusbio.com), today provided a corporate update.

"Since the beginning of this year, we have continued to focus our efforts on creating long-term value through our lead product Vitaros® and our lead product candidate Femprox®," said Richard Pascoe, Chief Executive Officer of Apricus Bio. "The recent approval of Vitaros® in Europe marked a significant milestone for Apricus and for our commercial partners Takeda, Sandoz, and Bracco.

Help employers find you! Check out all the jobs and post your resume.

//-->